SGLT2 Inhibitor Adds to Weight Loss With Phentermine (CME/CE)
(MedPage Today) -- Canagliflozin may have synergistic effect with standard obesity drug
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news
More News: Adipex | Canagliflozin | Cardiology | Cardiovascular | Eating Disorders & Weight Management | Heart | Invokana | Obesity | Phentermine | SGLT2 Inhibitors | Weight Loss